Spark Therapeutics Inc | Roche | Pennsylvania | state | | $150,000 | | grant |
Sandoz (Eon) | Sandoz Group | North Carolina | state | 2008 | $150,000 | | grant |
Eisai, Inc. | Eisai | North Carolina | state | 2009 | $150,000 | | grant |
Impax Laboratories USA, LLC | Amneal Pharmaceuticals | Pennsylvania | state | 2017 | $150,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | 2014 | $150,000 | | grant |
Chimerix, Inc. | Chimerix | North Carolina | state | 2017 | $148,326 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $147,996 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2013 | $147,484 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $147,230 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2012 | $146,985 | | enterprise zone |
Johnson & Johnson | Johnson & Johnson | New York | local | 2004 | $146,695 | | tax credit/rebate; property tax abatement |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2009 | $146,044 | | tax credit/rebate |
Bausch & Lomb | Bausch Health | New York | local | 2005 | $145,551 | | tax credit/rebate; property tax abatement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $145,490 | | tax credit/rebate |
Purdue Pharma LP | Purdue Pharma | New York | local | 2005 | $145,481 | | tax credit/rebate; property tax abatement |
Pharmacia Corporation | Pfizer | North Carolina | state | 2013 | $145,378 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2009 | $145,313 | | tax credit/rebate |
Eisai, Inc. | Eisai | Pennsylvania | state | 2016 | $144,716 | | tax credit/rebate |
PBM Nutritionals | Perrigo | Vermont | state | 2012 | $144,711 | | training reimbursement |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $143,927 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2010 | $143,721 | | enterprise zone |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $143,620 | | training reimbursement |
Amgen, Inc. | Amgen | Maryland | state | 2016 | $143,500 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Missouri | state | 2000 | $143,438 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $143,394 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $143,394 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2010 | $142,494 | | tax credit/rebate; property tax abatement |
Morphotek, Inc. | Eisai | United States | federal | 2012 | $141,901 | | federal grant |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2016 | $141,841 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2013 | $141,588 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | North Carolina | state | 1992 | $141,554 | | grant |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2005 | $141,146 | | tax credit/rebate |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2011 | $141,093 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2016 | $139,492 | | tax credit/rebate |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2010 | $138,219 | | grant |
Boehringer Ingleheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2009 | $138,096 | | tax credit/rebate |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2005 | $137,500 | | grant |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2009 | $137,500 | | training reimbursement |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2017 | $137,235 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2019 | $135,702 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2010 | $135,476 | | property tax abatement |
Bausch & Lomb Incorporated - Clearwater Facility | Bausch Health | Florida | state | 2005 | $135,000 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $134,250 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2022 | $133,565 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2015 | $132,577 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Maryland | state | 2008 | $131,514 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $131,488 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2018 | $131,371 | | tax credit/rebate |
Emergent Biosolutions Inc. And Subsidiaries | Emergent BioSolutions | Maryland | state | 2022 | $130,702 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Missouri | state | 2002 | $130,344 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $130,000 | | tax credit/rebate |
Auxilium Pharmaceuticals Inc. | Endo International | Pennsylvania | state | 2008 | $129,688 | | tax credit/rebate |
United Therapeutics Corporation & Subs | United Therapeutics | Maryland | state | 2019 | $129,675 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2011 | $129,618 | | property tax abatement |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2007 | $129,073 | | training reimbursement |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $127,860 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2015 | $127,208 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $126,863 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2008 | $126,743 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2015 | $126,734 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2017 | $126,234 | | tax credit/rebate |
CSL Behring LLC | CSL Limited | Pennsylvania | state | | $126,000 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2018 | $125,820 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | North Carolina | state | 2007 | $125,000 | | grant |
Wyeth Holdings LLC | Pfizer | North Carolina | state | 2019 | $125,000 | | grant |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2011 | $123,488 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2009 | $123,461 | | tax credit/rebate |
Pfizer Corporation | Pfizer | Maryland | state | 2007 | $123,426 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2021 | $121,874 | | tax credit/rebate |
LightLab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2012 | $121,636 | | tax credit/rebate |
DEY, L.P. | Viatris | California | state | 2005 | $121,613 | | training reimbursement |
SHIRE HUMAN GENETIC THERAPIES INC | Takeda Pharmaceutical | Pennsylvania | state | 2020 | $121,300 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $120,165 | | tax credit/rebate |
Auxillum Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | | $120,000 | | tax credit/rebate |
Biogen | Biogen | North Carolina | state | 1995 | $120,000 | | grant |
Bausch & Lomb Incorporated | Bausch Health | New York | Local | 2018 | $119,960 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2019 | $119,959 | | tax credit/rebate |
Innopharma Inc. | Pfizer | New Jersey | state | 2009 | $119,831 | | grant |
Regeneron 300 Valley View | Regeneron Pharmaceuticals | New York | local | 2021 | $119,479 | | tax credit/rebate |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2010 | $119,000 | | enterprise zone |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $118,253 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2011 | $118,136 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $117,680 | | tax credit/rebate |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2009 | $116,970 | | training reimbursement |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $116,856 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2007 | $116,504 | | tax credit/rebate |
IMMUNE DESIGN CORP. | Merck | Washington | state | 2017 | $115,926 | | tax credit/rebate |
IMMUNE DESIGN CORP. | Merck | Washington | state | 2018 | $115,926 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $115,708 | | tax credit/rebate |
Codman & Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $115,391 | | tax credit/rebate |
JAZZ PHARMACEUTICALS INC | Jazz Pharmaceuticals | Pennsylvania | state | 2020 | $115,000 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2014 | $114,848 | | tax credit/rebate |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2020 | $114,127 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $113,958 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $113,118 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2012 | $112,880 | | tax credit/rebate; property tax abatement |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $112,006 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2005 | $111,606 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2007 | $111,395 | | tax credit/rebate |